Performance of the American Heart Association's PREVENT Equations Among Disaggregated Racial and Ethnic Subgroups

Xiaowei Yan1,2, Adrian M Bacong3, Qiwen Huang1,2

  • 1Center for Health Systems Research, Sutter Health, Walnut Creek, California.

JAMA Cardiology
|June 25, 2025
PubMed

Insights

The Predicting Risk of Cardiovascular Disease (CVD) Events (PREVENT) equations showed good performance in diverse Asian and Hispanic subgroups. There was minor variation in risk prediction accuracy across disaggregated groups, indicating general applicability.

Area of Science:

  • Cardiovascular disease risk prediction
  • Health disparities research
  • Epidemiology

Background:

  • The Predicting Risk of Cardiovascular Disease (CVD) Events (PREVENT) equations are used for risk assessment.
  • Previous validation showed good performance across racial and ethnic groups.
  • Performance in disaggregated Asian and Hispanic subgroups was not well-described.

Purpose of the Study:

  • To evaluate the performance of the PREVENT equations in diverse racial and ethnic populations.
  • To specifically assess model performance in disaggregated Asian and Hispanic subgroups.
  • To determine if the PREVENT equations are applicable across these diverse populations.

Main Methods:

  • Retrospective electronic health record-based cohort study.
  • Included 361,778 primary care patients aged 30-79 years.
  • Assessed CVD events over a mean follow-up of 8.1 years using PREVENT equation predictors.

Main Results:

  • The PREVENT equations demonstrated good discrimination (C-statistics) and calibration across Asian and Hispanic populations.
  • Performance varied slightly among disaggregated Asian subgroups (e.g., Filipino, Asian Indian).
  • Calibration slopes were generally good, with some variation noted in Asian subgroups.

Conclusions:

  • The PREVENT equations are applicable to contemporary, diverse Asian and Hispanic patient populations.
  • Modest variations in performance were observed across disaggregated subgroups.
  • These findings support the use of PREVENT equations in diverse clinical settings.
Abstract

Related Concept Videos

Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
32
Pre-Procedural Guidelines for Assessing Blood Pressure01:10

Pre-Procedural Guidelines for Assessing Blood Pressure

Accurate blood pressure assessment is crucial for diagnosing and managing various health conditions. To ensure the reliability of these measurements, healthcare professionals must adhere to standardized pre-procedural guidelines. These guidelines enhance patient safety and improve the overall quality of healthcare. The following steps are essential for obtaining accurate and consistent blood pressure readings, from using the appropriate tools to ensuring effective communication with the...
625
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
33
Bias in Epidemiological Studies01:29

Bias in Epidemiological Studies

Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:  
666
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
505
Stereotypes, Prejudice, and Discrimination02:55

Stereotypes, Prejudice, and Discrimination

Humans are very diverse and although we share many similarities, we also have many differences. The social groups we belong to help form our identities (Tajfel, 1974). These differences may be difficult for some people to reconcile, which may lead to prejudice toward people who are different. Prejudice is a negative attitude and feeling toward an individual based solely on one’s membership in a particular social group (Allport, 1954; Brown, 2010). Prejudice is common against people who...
91.4K